Researchers have developed an AI model that accurately predicts which keratoconus patients require treatment by analyzing OCT eye scans and clinical data.
Key Details
- 1Study presented at the 43rd Congress of the European Society of Cataract and Refractive Surgeons (ESCRS).
- 2AI analyzed 36,673 OCT images from 6,684 patients with keratoconus.
- 3Algorithm could stratify two-thirds of patients as low-risk and one-third as high-risk for disease progression using data from a single visit.
- 4Including data from a second visit increased prediction accuracy to up to 90% of patients correctly categorized.
- 5Cross-linking treatment prevents vision loss and corneal transplantation in most cases if given early.
- 6Algorithm will undergo further safety testing before clinical deployment; researchers plan to expand to other eye conditions.
Why It Matters
Accurate early prediction of keratoconus progression through AI-augmented imaging could enable timely intervention, reduce unnecessary monitoring, and optimize healthcare resources, potentially preventing vision loss in young patients. This approach showcases the growing clinical impact of AI in ophthalmic imaging and patient stratification.
Source
EurekAlert
Related News
•EurekAlert
NIH Invests Additional $12.6M in USC-Led Imaging AI for Alzheimer's
NIH has renewed and expanded its support for a USC-led consortium developing AI to decode and treat Alzheimer's using imaging and genomic data.
•EurekAlert
USC Unveils Joint Biomedical Engineering Department Bridging Medicine, Engineering, and Imaging
USC's medical and engineering schools launch a joint biomedical engineering department to accelerate interdisciplinary research and innovation, including imaging and AI.
•EurekAlert
AI Predicts Risks for Outpatient Stem Cell Therapy in Myeloma
Researchers use machine learning to predict adverse events during stem cell therapy for multiple myeloma, improving outpatient safety.